Glaucoma Clinical Trial
— SALUSOfficial title:
SALUS - Selbsttonometrie Und Datentransfer Bei Glaukompatienten Zur Verbesserung Der Versorgungssituation
Verified date | January 2024 |
Source | University Hospital Muenster |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The SALUS project is developing a new form of care, the application of self-tonometry by the patient itself, and an accompanying electronic case file connecting clinics, doctor's offices and patients.
Status | Completed |
Enrollment | 267 |
Est. completion date | November 30, 2023 |
Est. primary completion date | October 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Requirement of a stationary day and night measurement - Statutory health insurance - Verified and suspicion of glaucoma diagnosis with suspicion of pressure variations and peaks or not attained target pressure or suspicion of glaucoma progression (H40.1, H40.2 und H42.-) - Willingness for therapy in one of the participating clinics - Adequate German language skills - Signed and dated informed consent for study participation and data transfer - Legal capacity of the insurant to agree to the study participation Exclusion Criteria: - Patients outside the catchment area of the participating clinics - Covering illnesses in psychiatry, neurology or other indications (e.g. impairment of independence) which make self-tonometry impossible - Strong communication barriers that do not allow the instruction to carry out the intervention - Unclear legal capacity of the potential study participants |
Country | Name | City | State |
---|---|---|---|
Germany | Klinikum Dortmund | Dortmund | |
Germany | St.-Johannes-Hospital Dortmund | Dortmund | |
Germany | Kath. Krankenhaus Hagen, St.-Josefs-Hospital | Hagen | |
Germany | Klinikum Luedenscheid | Lüdenscheid | |
Germany | University Hospital Muenster | Münster |
Lead Sponsor | Collaborator |
---|---|
University Hospital Muenster | AOK PLUS, BARMER, Bielefeld University, DAK Gesundheit, Federal Joint Committee, Fraunhofer Institute for Applied Information Technology FIT, IKK, KVWL |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of observed pressure peaks (>30% of the patient-specific target pressure) | Measurement of intraocular pressure by means of ICareHOME, rebound tonometry or Goldmann applanation tonometry. | 7 days (outpatient) or minimum 24 hours (stationary) | |
Secondary | Quality of life (patient-oriented) | By means of a questionnaire, 0: very bad state of health, 1: best possible state of health | Baseline and after 12 months | |
Secondary | Visual field index (VFI) | By means of perimetry | Baseline and after 9 and 12 months | |
Secondary | Mean deviation (MD) | By means of perimetry | Baseline and after 9 and 12 months | |
Secondary | Pattern standard deviation (PSD) | By means of perimetry | Baseline and after 9 and 12 months | |
Secondary | Retinal nerve fiber layer thickness | By means of Optical Coherence Tomography (OCT)/ Heidelberg Retina Tomography (HRT) | Baseline and after 12 months | |
Secondary | Rim volume | By means of Optical Coherence Tomography (OCT)/ Heidelberg Retina Tomography (HRT) | Baseline and after 12 months | |
Secondary | Rim area | By means of Optical Coherence Tomography (OCT)/ Heidelberg Retina Tomography (HRT) | Baseline and after 12 months | |
Secondary | Systolic and diastolic blood pressure | Long-term blood pressure measurement | for 24 hours during outpatient and stationary measurements of intraocular pressure | |
Secondary | Number of inpatient and outpatient health services | Care provider/ statutory health insurance (SHI) routine data | 12 month course | |
Secondary | Costs of health services | Care provider/ SHI routine data | 12 month course | |
Secondary | Number of periods of incapacity for work (unspecific and diagnosis-specific) | Interview/ SHI routine data | 12 month course | |
Secondary | Number of sick pay days | Interview/ SHI routine data | 12 month course |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
Completed |
NCT02653963 -
Triamcinolone for Ahmed Glaucoma Valve
|
N/A | |
Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
Completed |
NCT02520674 -
Glaucoma Screening With Smartphone Ophthalmology
|
N/A | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A |